There was a numerical reduction in red cell transfusion requirement, but the trial failed to reach statistical significance.
← all excerpts
Treatment of Hereditary Haemorrhagic Telangiectasia with Bevacizumab - What More Needs to be Known?
1
—
—
There was a numerical reduction in red cell transfusion requirement, but the trial failed to reach statistical significance.